• NEW
    R&D Strategic Technology Outlook
    Aug. 27, 2026

    The biomanufacturing landscape is shifting from fixed process settings, periodic sampling, and end-point testing toward real-time, data-driven process control. The growing complexity of biologics, cell and gene therapies, mRNA therapeutics, and antibody-drug conjugates is increasing the…